Your browser doesn't support javascript.
loading
t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs.
Narita, T; Inagaki, A; Kobayashi, T; Kuroda, Y; Fukushima, T; Nezu, M; Fuchida, S; Sakai, H; Sekiguchi, N; Sugiura, I; Maeda, Y; Takamatsu, H; Tsukamoto, N; Maruyama, D; Kubota, Y; Kojima, M; Sunami, K; Ono, T; Ri, M; Tobinai, K; Iida, S.
Afiliação
  • Narita T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Inagaki A; Department of Hematology and Oncology, Nagoya City West Medical Center, Nagoya, Japan.
  • Kobayashi T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kuroda Y; Department of Hematology and Oncology, Research Center for Radiation Casualty Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Fukushima T; Department of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan.
  • Nezu M; Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Fuchida S; Department of Hematology, Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Sakai H; Division of Hematology and Oncology, Department of Internal Medicine, St Marianna University School of Medicine, Kanagawa, Japan.
  • Sekiguchi N; Division of Hematology, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
  • Sugiura I; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Maeda Y; Department of Hematology and Oncology, Okayama University, Okayama, Japan.
  • Takamatsu H; Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
  • Tsukamoto N; Oncology Center, Gunma University Hospital, Maebashi, Japan.
  • Maruyama D; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Kubota Y; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Kojima M; Division of Hematology/Oncology, Department of Internal medicine, Tokai University School of Medicine, Isahara, Japan.
  • Sunami K; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Ono T; Department of Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Ri M; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Blood Cancer J ; 5: e285, 2015 Feb 27.
Article em En | MEDLINE | ID: mdl-25723856
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 14 / Cromossomos Humanos Par 16 / Antígeno CD56 / Mieloma Múltiplo Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 14 / Cromossomos Humanos Par 16 / Antígeno CD56 / Mieloma Múltiplo Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão